In a recent study, it was established that angiotensin-converting enzyme inhibitors and angiotensin receptor blockers were associated with reduced 30-day mortality following ischemic stroke but not haemorrhagic stroke [12]. The gene discussed is ACE; the disease is ischemic stroke.